Yukon Invests in Schryver Medical, Inc.
MINNEAPOLIS--(BUSINESS WIRE)--Yukon Partners ("Yukon") is pleased to announce its subordinated debt and equity investment in Schryver Medical, Inc. (“Schryver” or the “Company”).
“We are confident that with Revelstoke’s leadership alongside the strong reputation, operational expertise, and industry experience of the Company’s senior management team, Schryver will continue its impressive track record of growth.”
Schryver Medical, Inc., headquartered in Denver, Colorado, is a JCAHO accredited provider of mobile imaging diagnostics, clinical laboratory services, oxygen therapy and durable medical equipment rental. The Company serves nearly 2,000 long term post-acute facilities, assisted-living centers, and skilled nursing facilities, as well as numerous homecare patients. The multiple service lines offered help reduce costs, improve patient outcomes, and enable customers to serve higher acuity patients. Schryver’s significant value proposition and service line diversity have resulted in long term customer relationships and a superior brand reputation.
Revelstoke Capital Partners (“Revelstoke”) sponsored the transaction in which it, Yukon and other institutional co-investors acquired a majority equity interest in Schryver. Subordinated debt financing was led by Yukon. The senior credit facility was Agented and underwritten by Ally Corporate Finance. Management will continue to own a meaningful interest in the Company.
Revelstoke will provide Schryver strategic guidance and additional capital to accelerate its organic growth, pursue selective acquisitions, and continue to leverage its scalable business model for continued growth.
“We are pleased to partner with the Revelstoke team, who share our commitment to outstanding customer service,” said Mark Schryver, Founder of Schryver. “With their support, we have the ability to make investments that will further strengthen our capabilities and the value-added services we bring to our customers.”
“We are excited to partner with the Schryver Medical team to support the Company’s continued growth in the mobile imaging and laboratory diagnostics market,” noted Mark King, Managing Partner and CEO of Revelstoke. “We believe that the Schryver platform represents a compelling opportunity to invest in a differentiated service provider to the long term post-acute setting and are confident in the management team’s ability to further solidify its position as a leader in the industry. Schryver is well-positioned to accelerate its organic growth as well as pursue acquisitions that will further expand its service offerings and geographic coverage.”
“We are once again excited to be partnering with the Revelstoke team. Their hands-on approach and experience within the healthcare industry are attributes we greatly value,” said Michael Hall, Managing Partner of Yukon. “We are confident that with Revelstoke’s leadership alongside the strong reputation, operational expertise, and industry experience of the Company’s senior management team, Schryver will continue its impressive track record of growth.”
About Schryver Medical
Based in Denver, Colorado, and employing over 400 professionals, Schryver is a leading provider of mobile imaging, clinical laboratory, and oxygen therapy equipment outsourcing in the western United States serving the long term care market, hospitals, assisted-living centers, and homecare patients. For more information on Schryver, please visit www.schryvermedical.com.
About Yukon Partners
Yukon Partners is an independent and unaffiliated mezzanine finance firm primarily serving middle market private equity sponsored business transactions with a typical investment range of $10 to $40 million in the U.S. and Canada. The transactions in which Yukon invests include buyouts, growth and platform strategies, recapitalizations, mergers/acquisitions, public-to-private buyouts, and refinancings. Yukon Partners is based in Minneapolis, Minnesota. For more information, please visit www.yukonpartners.com.
About Revelstoke Capital Partners
Revelstoke is a private equity firm formed by experienced investors who strive to partner with management teams to execute on a disciplined organic and acquisition strategy to build industry-leading companies. Revelstoke’s Managing Partners, Mark King, Dale Meyer, and Simon Bachleda, have completed over 100 platform and add-on acquisitions, representing over $5 billion of total enterprise value. For more information, please visit www.revelstokecp.com.